UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease

Progress in neurobiology, 2007-04, Vol.81 (5-6), p.272-293

2007

Volltextzugriff (PDF)

Altered NMDA Receptor Trafficking in a Yeast Artificial Chromosome Transgenic Mouse Model of Huntington's Disease

The Journal of neuroscience, 2007-04, Vol.27 (14), p.3768-3779

2007

Volltextzugriff (PDF)

Polyglutamine-Modulated Striatal Calpain Activity in YAC Transgenic Huntington Disease Mouse Model: Impact on NMDA Receptor Function and Toxicity

The Journal of neuroscience, 2008-11, Vol.28 (48), p.12725-12735

2008

Volltextzugriff (PDF)

Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program

Pediatric blood & cancer, 2015-01, Vol.62 (1), p.65-71

2015

Volltextzugriff (PDF)

MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study

Neurology, 2018-01, Vol.90 (4), p.e264

2018

Volltextzugriff (PDF)

Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts

Leukemia research, 2010-09, Vol.34 (9), p.1214-1223

2010

Volltextzugriff (PDF)

Protective up-regulation of CK2 by mutant huntingtin in cells co-expressing NMDA receptors

Journal of neurochemistry, 2008-02, Vol.104 (3), p.790-805

2008

Volltextzugriff (PDF)

Proliferating neural precursor cells as first step toward neuroregeneration in Huntington's disease?

The Journal of neuroscience, 2006-12, Vol.26 (52), p.13411-13412

2006

Volltextzugriff (PDF)

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study

Lancet neurology, 2014-12, Vol.13 (12), p.1193-1201

2014

Volltextzugriff (PDF)

UTILITY OF COGNIGRAM IN TRIAGING PATIENTS FOR NEUROPSYCHOLOGICAL TESTING IN A TERTIARY MEMORY CLINIC

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P525-P526

2018

Volltextzugriff (PDF)

P1‐509: UTILITY OF COGNIGRAM IN TRIAGING PATIENTS FOR NEUROPSYCHOLOGICAL TESTING IN A TERTIARY MEMORY CLINIC

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_9), p.P525-P526

2018

Volltextzugriff (PDF)

The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer's Disease

Journal of Alzheimer's disease, 2022-01, Vol.87 (1), p.247-258

2022

Volltextzugriff (PDF)

GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through enhanced integrin α5β1-fibronectin interaction

Journal of cellular physiology, 2007-03, Vol.210 (3), p.757-765

2007

Volltextzugriff (PDF)

Proliferating Neural Precursor Cells as First Step toward Neuroregeneration in Huntington's Disease?: Table 1

The Journal of neuroscience, 2006-12, Vol.26 (52), p.13411-13412

2006

Volltextzugriff (PDF)

Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts

Leukemia & lymphoma, 2010-08, Vol.51 (8), p.1536-1542

2010

Volltextzugriff (PDF)

Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease

Neurobiology of aging, 2003-12, Vol.24 (8), p.1113-1121

2003

Volltextzugriff (PDF)

Regional atrophy associated with cognitive and motor function in prodromal Huntington disease

Journal of Huntington's disease, 2013, Vol.2 (4), p.477-489

2013

Volltextzugriff (PDF)

Leukemia Cell–Selective Uptake of Cytarabine and Daunorubicin in the Bone Marrow Compartment Mediated by CPX-351 Liposome Injection

Clinical lymphoma, myeloma and leukemia, 2010-06, Vol.10 (3), p.E29-E29

2010

Volltextzugriff (PDF)

GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through enhanced integrin alpha5beta1-fibronectin interaction

Journal of cellular physiology, 2007-03, Vol.210 (3), p.757-765

2007

Volltextzugriff (PDF)

The Small 11-kDa Protein from B19 Parvovirus Binds Growth Factor Receptor-Binding Protein 2 in Vitro in a Src Homology 3 Domain/Ligand-Dependent Manner

Virology (New York, N.Y.), 2001-12, Vol.291 (2), p.285-291

2001

Volltextzugriff (PDF)

Mechanisms of modulation of N-methyl-D-aspartate (NMDA) receptors by mutant huntingtin

Fan, Mannie Man Yee

2007

Volltextzugriff (PDF)

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Kidney international, 2021-03, Vol.99 (3), p.S1-S87

2021

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(21)
Dissertationen
(1)

Sprache

Englisch
(22)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(14)
Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Animals
(11)
Neurosciences & Neurology
(10)
Neurosciences
(9)
Mice
(7)
Female
(5)
Huntington Disease - Genetics
(5)
Cells, Cultured
(4)
Disease Models, Animal
(4)
Huntington Disease - Metabolism
(4)
Huntington Disease - Pathology
(4)
Male
(4)
Mice, Transgenic
(4)
Neurology
(4)
Receptors, N-Methyl-D-Aspartate - Metabolism
(4)
Acute Leukemia
(3)
Adult
(3)
Cell Line
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease

Altered NMDA Receptor Trafficking in a Yeast Artificial Chromosome Transgenic Mouse Model of Huntington's Disease

Polyglutamine-Modulated Striatal Calpain Activity in YAC Transgenic Huntington Disease Mouse Model: Impact on NMDA Receptor Function and Toxicity

Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program

MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study

Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts

Protective up-regulation of CK2 by mutant huntingtin in cells co-expressing NMDA receptors

Proliferating neural precursor cells as first step toward neuroregeneration in Huntington's disease?

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study

UTILITY OF COGNIGRAM IN TRIAGING PATIENTS FOR NEUROPSYCHOLOGICAL TESTING IN A TERTIARY MEMORY CLINIC

P1‐509: UTILITY OF COGNIGRAM IN TRIAGING PATIENTS FOR NEUROPSYCHOLOGICAL TESTING IN A TERTIARY MEMORY CLINIC

The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer's Disease

GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through enhanced integrin α5β1-fibronectin interaction

Proliferating Neural Precursor Cells as First Step toward Neuroregeneration in Huntington's Disease?: Table 1

Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts

Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease

Regional atrophy associated with cognitive and motor function in prodromal Huntington disease

Leukemia Cell–Selective Uptake of Cytarabine and Daunorubicin in the Bone Marrow Compartment Mediated by CPX-351 Liposome Injection

GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through enhanced integrin alpha5beta1-fibronectin interaction

The Small 11-kDa Protein from B19 Parvovirus Binds Growth Factor Receptor-Binding Protein 2 in Vitro in a Src Homology 3 Domain/Ligand-Dependent Manner

Mechanisms of modulation of N-methyl-D-aspartate (NMDA) receptors by mutant huntingtin

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Suchergebnisse filtern